Synopsis: Steinberg and colleagues show that the BRAF-inhibitor PLX4720 enhanced intratumoral Treg apoptosis and decreased both the proportion and the per-cell immunosuppressive function of MDSCs, thus informing the design of combinatorial therapies for melanoma. Synopsis: Bajor and colleagues used next-generation sequencing of TCRs in the tumor and blood to identify the emergence and persistence of a de novo T-cell repertoire following agonistic CD40 therapy, highlighting the potential of immune agonists in therapy and TCR deep sequencing in immune assessment. Synopsis: Singh and colleagues show that RNA-CAR T cells mediate rapid and long-term tumor destruction when delivered locally but not when delivered systemically due to the inability of RNA-CAR T cells to penetrate the tumor microenvironment. Synopsis: Paulson and colleagues report that 84% of Merkel cell carcinoma (MCC) tumors downregulated MHC-I expression, and MCC patients treated with intralesional IFNs had increased MHC-I expression on their tumor cells, thus promoting the use of immune-stimulating therapies for MCC.
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Selective Inhibition of Regulatory T Cells by Targeting the PI3K-Akt Pathway Rasha Abu-Eid, Raed N. Samara, Laurent Ozbun, Maher Y. Abdalla, Jay A. Berzofsky, Kevin M. Friedman, Mikayel Mkrtichyan, and Samir N. Khleif Synopsis: Abu-Eid, Samara, and colleagues used PI3K-Akt pathway inhibitors to selectively disrupt homeostasis of immunosuppressive Tregs in naïve and tumor-bearing mice, and to enhance vaccine-induced antitumor immune responses, highlighting the therapeutic potential of these inhibitors as Treg-depleting reagents.
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ABOUT THE COVER
The T-cell immunological synapse is a specialized junction formed between a T cell and an antigen-presenting cell. It comprises molecular interactions for antigen recognition regulating the immune response. The immunological synapse integrates three broad categories of receptors: antigen recognition (TCR), adhesion, and costimulatory/checkpoint. The organization of these receptors in the interface has an impact on the way they function. Antigen recognition begins with engagement of a TCR by an MHC-peptide complex. Adhesion molecules provide the energy needed to pull cells together, allowing sustained antigen recognition and precise execution of effector functions. Finally, costimulatory and checkpoint receptors alter the functional outcome of immunological synapse formation and signaling. The cover image is a scanning electronic micrograph showing the interaction between a CD4 þ T cell (green) and an antigen-presenting cell ( The Dustin laboratory has made substantial contributions to our understanding of T-cell surface molecules, the mechanism and regulation of T-cell migration in the lymph node and spleen, the mechanism of T-cell tolerance and activation in vivo by dendritic cells, and the modulation of T-cell immunological synapses. He has collaborated on intravital microscopy studies on breast and pancreatic cancers. The Dustin team in Oxford is developing new approaches to harness the immunological synapse as a therapeutic target in autoimmune disease and cancer.
Dr. Dustin has served on various scientific advisory boards and journal editorial boards. He is a fellow of the American Association for the Advancement of Sciences. He has received numerous awards, including a Presidential Early Career Award in Science and Engineering and the DART-NYU Biotechnology Award. He was also included in Esquire magazine's Best and Brightest in 2001. Dr. Dustin has organized various conferences on imaging of immunoreceptors and the immune system and authored over 250 peer-reviewed, original research papers, review articles, and book chapters. He is an enthusiastic teacher and has mentored over 40 graduate and postgraduate trainees. In addition, His lab has hosted over 20 visiting scientists from around the world. In keeping with his upbringing in the picturesque Hudson Valley, Dr. Dustin enjoys birding, cycling, and nature photography. v 
